MoneyWorks4Me

Ambalal Sarabhai Enterprises informs about compliance certificate

25 Apr 2022 Evaluate

Pursuant to the provisions of Regulation 7(3) of Securities Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, Ambalal Sarabhai Enterprises has informed that it enclosed Compliance Certificate for the Half year ended 31.03.2022 certifying that all activities in relation to the share transfer facility of the company are being maintained with SEBI registered R&T Agent MCS share transfer Agent.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..